会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明授权
    • Circulation-active fluoromethoxyphenyl dihydropyridine compounds
    • 循环活性氟甲氧基苯基二氢吡啶化合物
    • US5008279A
    • 1991-04-16
    • US263671
    • 1988-10-27
    • Gerhard FranckowiakJurgen StoltefussMartin BechemRainer GrossMichael KayserSiegbert HebischMatthias Schramm
    • Gerhard FranckowiakJurgen StoltefussMartin BechemRainer GrossMichael KayserSiegbert HebischMatthias Schramm
    • A61K31/445A61K31/451A61P9/08C07D211/90C07D401/12
    • C07D401/12C07D211/90
    • Circulation-active fluoromethoxyphenyldihydropyridines of the formula ##STR1## in which X stands for hydrogen or fluorine andR stands for straight-chain, branched or cyclic alkyl or alkenyl having 2 to 12 carbon atoms which can be interrupted by 1 to 2 oxygen and/or sulphur atoms in the chain, and which can be monosubstituted or polysubstituted(a) by hydroxyl, aryl having 6 to 12 carbon atoms, aryloxy having 6 to 12 carbon atoms, where the aryl radical is again substituted by alkyl having up to 4 carbon atoms, alkoxy having up to 4 carbon atoms or halogen, the substituents being identical or different, or(b) by carboxyl, alkoxycarbonyl having up to 6 carbon atoms, pyridyl, piperidyl, pyrimidyl, acyloxy having up to 7 carbon atoms, sulphamoyl, carbamoyl, halogen or cyano, the substituents being identical or different, or(c) by an amino group, where the amino group can carry one or two identical or different substituents from the group consisting of alkyl having up to 6 carbon atoms, benzyl, phenyl or acyl having up to 7 carbon atoms,and salts thereof.
    • 式(I)的循环活性氟甲氧基苯基二氢吡啶,其中X代表氢或氟,R代表可被1至2个氧中断的具有2至12个碳原子的直链,支链或环状烷基或链烯基 和/或链中的硫原子,并且其可以被羟基,具有6至12个碳原子的芳基,具有6至12个碳原子的芳氧基单取代或多取代(a),其中芳基再次被具有至多 4个碳原子,具有至多4个碳原子的烷氧基或卤素,取代基相同或不同,或(b)由羧基,具有至多6个碳原子的烷氧基羰基,吡啶基,哌啶基,嘧啶基,具有至多7个碳原子的酰氧基, 氨基甲酰基,氨基甲酰基,卤素或氰基,取代基相同或不同,或(c)氨基,其中氨基可以带有一个或两个相同或不同的取代基,由至多6个碳原子的烷基 ms,苄基,苯基或具有至多7个碳原子的酰基及其盐。
    • 29. 发明授权
    • 3-Nitro-5-amide-1,4-dihydropyridines with positive inotropic activity
    • 具有正性肌力活性的3-硝基-5-酰胺-1,4-二氢吡啶
    • US4540684A
    • 1985-09-10
    • US612093
    • 1984-05-18
    • Jurgen StoltefussGerhard FranckowiakHorst BoshagenSiegfried GoldmannMatthias SchrammGunter ThomasRainer Gross
    • Jurgen StoltefussGerhard FranckowiakHorst BoshagenSiegfried GoldmannMatthias SchrammGunter ThomasRainer Gross
    • A61K31/455A61P3/08A61P9/02A61P9/04C07D211/90C07D211/98A61K31/70C07D405/12
    • C07D211/90
    • A 1,4-dihydropyridine derivative of the formula ##STR1## in which R and R.sub.1 each independently is hydrogen, C.sub.1 -C.sub.4 -alkyl, C.sub.1 to C.sub.12 -alkoxy, C.sub.1 -C.sub.4 -halogenoalkoxy, halogen, nitro, trifluoromethyl, ##STR2## X is oxygen or sulphur, R.sub.4 and R.sub.5 each independently is hydrogen, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.6 -alkoxy, halogen, trifluoromethyl, amino or nitro, andR.sub.2 and R.sub.3 each independently is hydrogen, a C.sub.1 -C.sub.10 -alkyl, C.sub.2 -C.sub.10 -alkenyl or C.sub.3 -C.sub.10 -alkinyl radical which is optionally substituted by halogen, hydroxyl, C.sub.1 -C.sub.4 -alkoxy, amino, mono- and di-C.sub.1 -C.sub.4 -alkylamino, carbo-C.sub.1 -C.sub.6 -alkoxy and/or nitro, a C.sub.3 to C.sub.6 -membered cycloalkyl radical, a phenyl radical which is optionally substituted by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.6 -alkoxy, halogen, amino and/or nitro, or a phenyl-C.sub.1 -C.sub.3 -alkyl radical, or a carbohydrate radical which is optionally bonded via a C.sub.1 -C.sub.8 -alkyl chain to the amide nitrogen atomor a pharmaceutically acceptable acid addition salt thereof, which improves the contractility of the heart, raises the blood pressure, lowers the blood sugar, reduces the swelling of mucous membranes and affects the salt and fluid balances of a patient.
    • 其中R和R 1各自独立地为氢,C 1 -C 4 - 烷基,C 1 -C 12 - 烷氧基,C 1 -C 4卤代烷氧基,卤素,硝基,三氟甲基, X是氧或硫,R4和R5各自独立地是氢,C1-C4-烷基,C1-C6-烷氧基,卤素,三氟甲基,氨基或硝基,R2和R3各自独立地是氢,C1-C10 - 烷基,C 2 -C 10 - 烯基或C 3 -C 10 - 炔基,其任选被卤素,羟基,C 1 -C 4 - 烷氧基,氨基,单 - 和二-C 1 -C 4 - 烷基氨基,C 1 -C 6 - 和/或硝基,C3至C6元环烷基,任选被C 1 -C 4 - 烷基,C 1 -C 6 - 烷氧基,卤素,氨基和/或硝基取代的苯基,或苯基-C 1 -C 3 - 烷基或通过C1-C8烷基链任选与酰胺氮原子键合的碳水化合物基团或其药学上可接受的酸加成盐,其改善心脏的收缩力,使血压升高 ure,降低血糖,减少粘膜肿胀,影响患者的盐和液体平衡。